18 results
PRER14A
GLSHQ
Gelesis Holdings, Inc.
7 Sep 23
Preliminary revised proxy
4:03pm
an important place in the market for patients due to its safety and tolerability profile and comparative affordability and to operate the Company as a
private … , and affordability to the consumer. Accordingly, we believe it is important that Plenity be widely available and easily accessible to consumers
PREM14A
GLSHQ
Gelesis Holdings, Inc.
24 Jul 23
Preliminary proxy related to merger
9:47pm
an important place in the market for patients due to its safety and tolerability profile and comparative affordability and to operate the Company … -to-efficacy profile, broad approved labeling, and affordability to the consumer. Accordingly, we believe it is important that Plenity be widely available
DEF 14A
GLSHQ
Gelesis Holdings, Inc.
26 Jun 23
Definitive proxy
5:26pm
or exercise during treatment
Plenity has the potential to be a weight loss solution for a broad population given the treatment’s wide label, affordability
424B3
5uqb6il
16 Nov 22
Prospectus supplement
4:51pm
424B3
uem9pho1yl1n6224s1
16 Nov 22
Prospectus supplement
4:48pm
8-K
EX-99.1
9fx59 nzwww9
14 Nov 22
Gelesis Reports Third Quarter 2022 Results
8:56am
424B3
9otohg
27 Dec 21
Prospectus supplement
12:00am
S-4/A
vub7j6iq 7k5
29 Sep 21
Registration of securities issued in business combination transactions (amended)
5:08pm
S-4
psttlfkfnye6j5
10 Aug 21
Registration of securities issued in business combination transactions
5:24pm
- Prev
- 1
- Next